[Screening of Chagas disease using ELISA. Comparison of 2 antigens].
After proving, in a previous study, the efficiency of immunoenzymology (ELISA) and a primary antigen of Trypanosoma cruzi in the screening of blood donors suffering from Chagas' disease, here the authors show the benefit of the microsomial fraction of this parasite as an antigen. For comparison, it was studied with another primary antigen, Trypanosa, used initially in the adjuvant treatment of cancers, and applied here to the screening of this disease.